U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Monoclonal immunoglobulin M proteinemia

MedGen UID:
1381967
Concept ID:
C4477091
Neoplastic Process
Synonym: Waldenstrom macroglobulinemia
 
HPO: HP:0005508

Definition

Presence of a monoclonal immunoglobulin M protein in the serum. [from HPO]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVMonoclonal immunoglobulin M proteinemia

Conditions with this feature

Macroglobulinemia, Waldenstrom, 1
MedGen UID:
320546
Concept ID:
C1835192
Disease or Syndrome
Waldenstrom macroglobulinemia (WM) is a malignant B-cell neoplasm characterized by lymphoplasmacytic infiltration of the bone marrow and hypersecretion of monoclonal immunoglobulin M (IgM) protein (review by Vijay and Gertz, 2007). The importance of genetic factors is suggested by the observation of familial clustering of WM (McMaster, 2003). Whereas WM is rare, an asymptomatic elevation of monoclonal IgM protein, termed 'IgM monoclonal gammopathy of undetermined significance' (IgM MGUS) is more common. Patients with IgM MGUS can progress to develop WM, at the rate of 1.5% to 2% per year (Kyle et al., 2003). Genetic Heterogeneity of Waldenstrom Macroglobulinemia A locus for susceptibility to Waldenstrom macroglobulinemia (WM2; 610430) has been mapped to chromosome 4q.

Professional guidelines

PubMed

Clark R, Katzmann JA, Kyle RA, Fleisher M, Landers JP
Electrophoresis 1998 Oct;19(14):2479-84. doi: 10.1002/elps.1150191421. PMID: 9820971

Recent clinical studies

Etiology

Lu J, Zhu Y, Huang H, Yang Q, Qi S
BMC Immunol 2024 Oct 30;25(1):73. doi: 10.1186/s12865-024-00664-6. PMID: 39478462Free PMC Article
Fujimura K, Sugiyama A, Akita T, Ohisa M, Nagashima S, Katayama K, Maeda R, Tanaka J
Int J Hematol 2021 Apr;113(4):576-585. Epub 2021 Jan 3 doi: 10.1007/s12185-020-03045-y. PMID: 33389658
Clark R, Katzmann JA, Kyle RA, Fleisher M, Landers JP
Electrophoresis 1998 Oct;19(14):2479-84. doi: 10.1002/elps.1150191421. PMID: 9820971
Kyle RA
Mayo Clin Proc 1975 Jan;50(1):29-40. PMID: 1110582

Diagnosis

Lu J, Zhu Y, Huang H, Yang Q, Qi S
BMC Immunol 2024 Oct 30;25(1):73. doi: 10.1186/s12865-024-00664-6. PMID: 39478462Free PMC Article
Fujimura K, Sugiyama A, Akita T, Ohisa M, Nagashima S, Katayama K, Maeda R, Tanaka J
Int J Hematol 2021 Apr;113(4):576-585. Epub 2021 Jan 3 doi: 10.1007/s12185-020-03045-y. PMID: 33389658
Adachi M, Kitamura M, Muta K, Maekawa A, Uramatsu T, Tadokoro M, Funakoshi S, Hisano S, Kuwahara N, Shimizu A, Mukae H, Nishino T
BMC Nephrol 2020 May 24;21(1):195. doi: 10.1186/s12882-020-01851-4. PMID: 32448180Free PMC Article
Clark R, Katzmann JA, Kyle RA, Fleisher M, Landers JP
Electrophoresis 1998 Oct;19(14):2479-84. doi: 10.1002/elps.1150191421. PMID: 9820971
Komatsu M, Ehara T, Kuroda T
Surg Today 1996;26(3):213-6. doi: 10.1007/BF00311511. PMID: 8845618

Therapy

Kyle RA
Mayo Clin Proc 1975 Jan;50(1):29-40. PMID: 1110582

Prognosis

Fujimura K, Sugiyama A, Akita T, Ohisa M, Nagashima S, Katayama K, Maeda R, Tanaka J
Int J Hematol 2021 Apr;113(4):576-585. Epub 2021 Jan 3 doi: 10.1007/s12185-020-03045-y. PMID: 33389658
Kyle RA
Mayo Clin Proc 1975 Jan;50(1):29-40. PMID: 1110582

Clinical prediction guides

Clark R, Katzmann JA, Kyle RA, Fleisher M, Landers JP
Electrophoresis 1998 Oct;19(14):2479-84. doi: 10.1002/elps.1150191421. PMID: 9820971

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...